| Line item | Value |
|---|---|
| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | YoY | Trend | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current Assets | €504.2M | €399.1M | €367.9M | €275.0M | €302.0M | €221.4M | +26.3% | |
| Inventories | €103.8M | €90.5M | €76.9M | €70.4M | €57.9M | €46.8M | +14.8% | |
| Trade Receivables | €193.3M | €166.5M | €152.0M | €120.1M | €94.5M | €82.9M | +16.1% | |
| Non-Current Assets | €1.0B | €993.0M | €875.6M | €820.0M | €690.1M | €622.8M | +4.0% | |
| Cash & Equivalents | €121.9M | €98.3M | €131.2M | €76.4M | €132.2M | €81.3M | +24.0% | |
| Property, Plant & Equipment | €648.1M | €580.4M | €474.3M | €428.2M | €307.7M | €258.2M | +11.7% | |
| Goodwill | €222.8M | €230.1M | €222.9M | €225.2M | €224.8M | €216.5M | -3.1% | |
| Intangible Assets | €147.9M | €150.4M | €147.8M | €146.7M | €144.7M | €140.0M | -1.7% | |
| Deferred Tax Assets | €4.0M | €2.5M | €2.1M | €2.2M | €2.2M | €3.4M | +59.2% | |
| Total Assets | €1.5B | €1.4B | €1.2B | €1.1B | €992.1M | €844.2M | +10.4% | |
| Liabilities | ||||||||
| Current Liabilities | €339.5M | €339.0M | €237.4M | €256.7M | €183.1M | €148.6M | +0.1% | |
| Trade Payables | €247.6M | €216.3M | €205.1M | €173.0M | — | — | +14.5% | |
| Non-Current Liabilities | €337.4M | €262.0M | €349.9M | €266.2M | €289.4M | €261.8M | +28.8% | |
| Deferred Tax Liabilities | €78.4M | €74.6M | €68.0M | €63.7M | €64.2M | €57.2M | +5.0% | |
| Equity | ||||||||
| Share Capital | — | — | — | — | €16.4M | €16.4M | — | |
| Retained Earnings | €924.8M | €811.0M | €704.4M | €611.2M | €539.6M | €476.7M | +14.0% | |
| Other Reserves | -€58.1M | -€19.3M | -€45.8M | -€36.5M | -€26.9M | -€48.0M | -201.0% | |
| Minority Interests | — | — | — | — | — | €67K | — | |
| Total Equity | €859.6M | €791.2M | €656.2M | €572.1M | €519.5M | €433.7M | +8.7% | |
New to Ticker
Create a free Ticker account to see every line of the income statement, balance sheet and cash flow, plus dividends and financial health.
Sign up freeAlready have an account? Sign in
Already a member
Welcome back
Sign in to pick up where you left off, with full access to every page.
Sign in